One Week Left to Submit Late Breaking Abstracts! 2023 TERMIS-AM Annual Conference
0 comments
by Amanda Clifford
Dear CBS Members, There is only one week left to submit late breaking abstracts for the annual TERMIS-AM conference this April in Boston You can submit your abstracts here...
Dear Members, Abstract submission is open for CBS 2023 at Dalhousie University in Halifax, NS. Please submit your abstract on the conference website www...
Injectable hydrogels that can be delivered using needles offer particular advantages in biomedical applications given that these hydrogels do not require invasive surgical implantation, thereby reducing recovery time for patients, reducing costs, and in many cases enabling direct encapsulation, rather than post-encapsulation, of cells during the gel formation process 1 ...
A Thermoresponsive Composite Hydrogel with pH dependent H2S Release Capabilities for Dental Pulp Stem Cells Capsulated for Local Treatment of Spinal Cord Injury
comments
Doxorubicin is widespread and influential apoptosis-inducing drug in cancer chemotherapy which interdicts DNA replication and treats different types of cancers including, benign, potentially-malignant, glioblastoma malignant tumours 1 2 3 ...